Moreover, preclinical data from cell lines and animal models indicate that approaches targeting subunits of KAT6A and KAT6B can effectively inhibit tumor growth via mechanisms including cell cycle arrest and cell senescence [36]. Here, KAT6A is linked to neoplasm.